Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2WS25/− mouse model of autosomal dominant polycystic kidney disease
- 22 January 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 32 (3) , 401-409
Abstract
Increased levels of cyclooxygenase (COX) derived oxylipins is the earliest and most consistent alteration in the renal oxylipin profile in diverse models of cystic kidney diseases. Therefore, we examined whether a COX2 inhibitor would reduce disease progression in the Pkd2WS25/− mouse model of autosomal dominant polycystic kidney disease (ADPKD).Keywords
Funding Information
- Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-03733)
This publication has 56 references indexed in Scilit:
- Nephronophthisis: A review of genotype–phenotype correlationNephrology, 2018
- Distinct oxylipin alterations in diverse models of cystic kidney diseasesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017
- Defective glycolysis and the use of 2-deoxy-d-glucose in polycystic kidney disease: from animal models to humansJournal Of Nephrology, 2017
- Advances in Our Understanding of Oxylipins Derived from Dietary PUFAsAdvances in Nutrition, 2015
- Dietary flax oil rich in α-linolenic acid reduces renal disease and oxylipin abnormalities, including formation of docosahexaenoic acid derived oxylipins in the CD1-pcy/pcy mouse model of nephronophthisisProstaglandins, Leukotrienes and Essential Fatty Acids, 2015
- Renal Cyclooxygenase Products are Higher and Lipoxygenase Products are Lower in Early Disease in the pcy Mouse Model of Adolescent NephronophthisisLipids, 2013
- Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD‐CyratMolecular Nutrition & Food Research, 2013
- Polycystic Kidney DiseaseAnnual Review of Medicine, 2009
- Emerging roles for eicosanoids in renal diseasesCurrent Opinion in Nephrology and Hypertension, 2009
- End-Stage Renal Failure Appears Earlier in Men Than in Women With Polycystic Kidney DiseaseAmerican Journal of Kidney Diseases, 1994